Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The cancer nanomedicine field is heading in two directions — debating whether the clinical translation of nanomaterials should be accelerated or whether some of the long-standing drug delivery paradigms have to be challenged first.
The coordinating role of the National Nanotechnology Initiative will be essential for the development of research at the nanoscale in the next decades.
The trade-off between necessary scientific communication and the associated CO2 footprint asks for a thorough reconsideration of our travelling habits, new institutional travelling policies and for alternative approaches to interaction with colleagues and peers.
After our call to action regarding the suitability and usefulness of a checklist for papers in the field of nanobiomedicine, we received mixed replies.
Plastic nanoparticles raise concern because of their potential impact on the environment. However, many questions need to be answered to establish how dangerous they really are.
The connection between properties and environmental performance of graphene-derived structures is necessary to develop materials that can improve industry standards.
The proposal for a reporting checklist for papers published in the area of nanobiomedicine is an opportunity to rekindle a conversation that started six years ago.